1. Home
  2. LOVE vs SGMO Comparison

LOVE vs SGMO Comparison

Compare LOVE & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$12.54

Market Cap

177.7M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.46

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOVE
SGMO
Founded
1998
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.7M
155.1M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
LOVE
SGMO
Price
$12.54
$0.46
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$30.00
$4.71
AVG Volume (30 Days)
612.1K
9.2M
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
5.90
N/A
EPS
0.46
N/A
Revenue
$690,559,000.00
$32,875,000.00
Revenue This Year
$6.93
$1.37
Revenue Next Year
$7.52
N/A
P/E Ratio
$27.84
N/A
Revenue Growth
0.13
N/A
52 Week Low
$11.26
$0.38
52 Week High
$38.67
$2.84

Technical Indicators

Market Signals
Indicator
LOVE
SGMO
Relative Strength Index (RSI) 38.92 44.69
Support Level $13.76 $0.49
Resistance Level $14.04 $0.51
Average True Range (ATR) 0.68 0.05
MACD 0.07 0.01
Stochastic Oscillator 38.00 37.85

Price Performance

Historical Comparison
LOVE
SGMO

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: